Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Design of future rabies biologics and antiviral drugs.

Smith TG, Wu X, Franka R, Rupprecht CE.

Adv Virus Res. 2011;79:345-63. doi: 10.1016/B978-0-12-387040-7.00016-0. Review.

PMID:
21601054
2.

Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.

Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett SM, Levis R, Meltzer MI, Schaffner W, Cieslak PR; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Mar 19;59(RR-2):1-9. Erratum in: MMWR Recomm Rep. 2010 Apr 30;59(16):493.

3.

Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.

Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, Sun B, Hull HF; Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 May 23;57(RR-3):1-28.

4.

[Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].

Koprowski H.

Arch Immunol Ther Exp (Warsz). 2002;50(6):365-9. Polish.

PMID:
12549429
5.

Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.

Müller T, Dietzschold B, Ertl H, Fooks AR, Freuling C, Fehlner-Gardiner C, Kliemt J, Meslin FX, Franka R, Rupprecht CE, Tordo N, Wanderler AI, Kieny MP.

PLoS Negl Trop Dis. 2009 Nov 3;3(11):e542. doi: 10.1371/journal.pntd.0000542. Erratum in: PLoS Negl Trop Dis. 2009;3(11): doi: 10.1371/annotation/df98339d-6bdb-40ed-af83-cc38b249264a. Franka, Richard [added].

6.

Postexposure prophylaxis for rabies in resource-limited/poor countries.

Shantavasinkul P, Wilde H.

Adv Virus Res. 2011;79:291-307. doi: 10.1016/B978-0-12-387040-7.00013-5. Review.

PMID:
21601051
7.

The incurable wound revisited: progress in human rabies prevention?

Hanlon CA, Niezgoda M, Morrill PA, Rupprecht CE.

Vaccine. 2001 Mar 21;19(17-19):2273-9.

PMID:
11257347
8.

Human rabies encephalitis prevention and treatment: progress since Pasteur's discovery.

Dacheux L, Delmas O, Bourhy H.

Infect Disord Drug Targets. 2011 Jun;11(3):251-99. Review.

PMID:
21488832
9.

Reinvestigating the role of IgM in rabies virus postexposure vaccination.

Dorfmeier CL, Shen S, Tzvetkov EP, McGettigan JP.

J Virol. 2013 Aug;87(16):9217-22. doi: 10.1128/JVI.00995-13. Epub 2013 Jun 12.

10.

Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.

Sun L, Chen Z, Yu L, Wei J, Li C, Jin J, Shen X, Lv X, Tang Q, Li D, Liang M.

Appl Microbiol Biotechnol. 2012 Oct;96(2):357-66. doi: 10.1007/s00253-012-4171-4. Epub 2012 Jun 9.

PMID:
22678022
11.

Human monoclonal antibody and vaccine approaches to prevent human rabies.

Nagarajan T, Rupprecht CE, Dessain SK, Rangarajan PN, Thiagarajan D, Srinivasan VA.

Curr Top Microbiol Immunol. 2008;317:67-101. Review.

PMID:
17990790
12.

Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.

Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, Rice AB, Kruif Jd, Dietzschold B, Bakker AB, Rupprecht CE.

J Infect Dis. 2006 Mar 15;193(6):796-801. Epub 2006 Feb 6.

13.

New approaches to the prevention and eradication of rabies.

Dietzschold B, Faber M, Schnell MJ.

Expert Rev Vaccines. 2003 Jun;2(3):399-406. Review.

PMID:
12903805
14.

Rabies research in resource-poor countries.

Wilde H, Lumlertdacha B.

Adv Virus Res. 2011;79:449-55. doi: 10.1016/B978-0-12-387040-7.00021-4. Review.

PMID:
21601059
15.

Treatment of rabies in the 21st century: curing the incurable?

Franka R, Rupprecht CE.

Future Microbiol. 2011 Oct;6(10):1135-40. doi: 10.2217/fmb.11.92.

PMID:
22004032
16.

Immunogenicity and efficacy of Fermi-type nerve tissue rabies vaccine in mice and in humans undergoing post-exposure prophylaxis for rabies in Ethiopia.

Ayele W, Fekadu M, Zewdie B, Beyene M, Bogale Y, Mocha K, Egziabher FG.

Ethiop Med J. 2001 Oct;39(4):313-21.

PMID:
12380231
17.

The challenge to provide affordable rabies post-exposure treatment.

Warrell MJ.

Vaccine. 2003 Jan 30;21(7-8):706-9.

PMID:
12531345
18.

Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals.

Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett S, Levis R, Meltzer MI, Schaffner W, Cieslak PR.

Vaccine. 2009 Nov 27;27(51):7141-8. doi: 10.1016/j.vaccine.2009.09.029. Review.

PMID:
19925944
19.

Small interfering RNAs targeting the rabies virus nucleoprotein gene.

Yang YJ, Zhao PS, Zhang T, Wang HL, Liang HR, Zhao LL, Wu HX, Wang TC, Yang ST, Xia XZ.

Virus Res. 2012 Oct;169(1):169-74. doi: 10.1016/j.virusres.2012.07.024. Epub 2012 Aug 3.

PMID:
22884777
20.

Therapy of human rabies.

Jackson AC.

Adv Virus Res. 2011;79:365-75. doi: 10.1016/B978-0-12-387040-7.00017-2. Review.

PMID:
21601055
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk